29
|
Kuchenbaecker KB, McGuffog L, Barrowdale D, Lee A, Soucy P, Healey S, Dennis J, Lush M, Robson M, Spurdle AB, Ramus SJ, Mavaddat N, Terry MB, Neuhausen SL, Hamann U, Southey M, John EM, Chung WK, Daly MB, Buys SS, Goldgar DE, Dorfling CM, van Rensburg EJ, Ding YC, Ejlertsen B, Gerdes AM, Hansen TVO, Slager S, Hallberg E, Benitez J, Osorio A, Cohen N, Lawler W, Weitzel JN, Peterlongo P, Pensotti V, Dolcetti R, Barile M, Bonanni B, Azzollini J, Manoukian S, Peissel B, Radice P, Savarese A, Papi L, Giannini G, Fostira F, Konstantopoulou I, Adlard J, Brewer C, Cook J, Davidson R, Eccles D, Eeles R, Ellis S, Frost D, Hodgson S, Izatt L, Lalloo F, Ong KR, Godwin AK, Arnold N, Dworniczak B, Engel C, Gehrig A, Hahnen E, Hauke J, Kast K, Meindl A, Niederacher D, Schmutzler RK, Varon-Mateeva R, Wang-Gohrke S, Wappenschmidt B, Barjhoux L, Collonge-Rame MA, Elan C, Golmard L, Barouk-Simonet E, Lesueur F, Mazoyer S, Sokolowska J, Stoppa-Lyonnet D, Isaacs C, Claes KBM, Poppe B, de la Hoya M, Garcia-Barberan V, Aittomäki K, Nevanlinna H, Ausems MGEM, de Lange JL, Gómez Garcia EB, Hogervorst FBL, Kets CM, Meijers-Heijboer HEJ, Oosterwijk JC, Rookus MA, van Asperen CJ, van den Ouweland AMW, van Doorn HC, van Os TAM, Kwong A, Olah E, Diez O, Brunet J, Lazaro C, Teulé A, Gronwald J, Jakubowska A, Kaczmarek K, Lubinski J, Sukiennicki G, Barkardottir RB, Chiquette J, Agata S, Montagna M, Teixeira MR, Park SK, Olswold C, Tischkowitz M, Foretova L, Gaddam P, Vijai J, Pfeiler G, Rappaport-Fuerhauser C, Singer CF, Tea MKM, Greene MH, Loud JT, Rennert G, Imyanitov EN, Hulick PJ, Hays JL, Piedmonte M, Rodriguez GC, Martyn J, Glendon G, Mulligan AM, Andrulis IL, Toland AE, Jensen UB, Kruse TA, Pedersen IS, Thomassen M, Caligo MA, Teo SH, Berger R, Friedman E, Laitman Y, Arver B, Borg A, Ehrencrona H, Rantala J, Olopade OI, Ganz PA, Nussbaum RL, Bradbury AR, Domchek SM, Nathanson KL, Arun BK, James P, Karlan BY, Lester J, Simard J, Pharoah PDP, Offit K, Couch FJ, Chenevix-Trench G, Easton DF, Antoniou AC. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers. J Natl Cancer Inst 2017; 109:3064534. [PMID: 28376175 PMCID: PMC5408990 DOI: 10.1093/jnci/djw302] [Citation(s) in RCA: 189] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2016] [Revised: 10/15/2016] [Accepted: 11/16/2016] [Indexed: 12/16/2022] Open
Abstract
Background Genome-wide association studies (GWAS) have identified 94 common single-nucleotide polymorphisms (SNPs) associated with breast cancer (BC) risk and 18 associated with ovarian cancer (OC) risk. Several of these are also associated with risk of BC or OC for women who carry a pathogenic mutation in the high-risk BC and OC genes BRCA1 or BRCA2. The combined effects of these variants on BC or OC risk for BRCA1 and BRCA2 mutation carriers have not yet been assessed while their clinical management could benefit from improved personalized risk estimates. Methods We constructed polygenic risk scores (PRS) using BC and OC susceptibility SNPs identified through population-based GWAS: for BC (overall, estrogen receptor [ER]-positive, and ER-negative) and for OC. Using data from 15 252 female BRCA1 and 8211 BRCA2 carriers, the association of each PRS with BC or OC risk was evaluated using a weighted cohort approach, with time to diagnosis as the outcome and estimation of the hazard ratios (HRs) per standard deviation increase in the PRS. Results The PRS for ER-negative BC displayed the strongest association with BC risk in BRCA1 carriers (HR = 1.27, 95% confidence interval [CI] = 1.23 to 1.31, P = 8.2×10 -53 ). In BRCA2 carriers, the strongest association with BC risk was seen for the overall BC PRS (HR = 1.22, 95% CI = 1.17 to 1.28, P = 7.2×10 -20 ). The OC PRS was strongly associated with OC risk for both BRCA1 and BRCA2 carriers. These translate to differences in absolute risks (more than 10% in each case) between the top and bottom deciles of the PRS distribution; for example, the OC risk was 6% by age 80 years for BRCA2 carriers at the 10th percentile of the OC PRS compared with 19% risk for those at the 90th percentile of PRS. Conclusions BC and OC PRS are predictive of cancer risk in BRCA1 and BRCA2 carriers. Incorporation of the PRS into risk prediction models has promise to better inform decisions on cancer risk management.
Collapse
Affiliation(s)
- Karoline B. Kuchenbaecker
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Lesley McGuffog
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Daniel Barrowdale
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Andrew Lee
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Penny Soucy
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Sue Healey
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Joe Dennis
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Michael Lush
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Mark Robson
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Amanda B. Spurdle
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Susan J. Ramus
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Nasim Mavaddat
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Mary Beth Terry
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Susan L. Neuhausen
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Ute Hamann
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Melissa Southey
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Esther M. John
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Wendy K. Chung
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Mary B. Daly
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Saundra S. Buys
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - David E. Goldgar
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Cecilia M. Dorfling
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Elizabeth J. van Rensburg
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Yuan Chun Ding
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Bent Ejlertsen
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Anne-Marie Gerdes
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Thomas V. O. Hansen
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Susan Slager
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Emily Hallberg
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Javier Benitez
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Ana Osorio
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Nancy Cohen
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - William Lawler
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jeffrey N. Weitzel
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Paolo Peterlongo
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Valeria Pensotti
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Riccardo Dolcetti
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Monica Barile
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Bernardo Bonanni
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jacopo Azzollini
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Siranoush Manoukian
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Bernard Peissel
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Paolo Radice
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Antonella Savarese
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Laura Papi
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Giuseppe Giannini
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Florentia Fostira
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Irene Konstantopoulou
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Julian Adlard
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Carole Brewer
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jackie Cook
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Rosemarie Davidson
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Diana Eccles
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Ros Eeles
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Steve Ellis
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | | | - Debra Frost
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Shirley Hodgson
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Louise Izatt
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Fiona Lalloo
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Kai-ren Ong
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Andrew K. Godwin
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Norbert Arnold
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Bernd Dworniczak
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Christoph Engel
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Andrea Gehrig
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Eric Hahnen
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jan Hauke
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Karin Kast
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Alfons Meindl
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Dieter Niederacher
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Rita Katharina Schmutzler
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Raymonda Varon-Mateeva
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Shan Wang-Gohrke
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Barbara Wappenschmidt
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Laure Barjhoux
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Marie-Agnès Collonge-Rame
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Camille Elan
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | | | - Lisa Golmard
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Emmanuelle Barouk-Simonet
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Fabienne Lesueur
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Sylvie Mazoyer
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Joanna Sokolowska
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Dominique Stoppa-Lyonnet
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Claudine Isaacs
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Kathleen B. M. Claes
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Bruce Poppe
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Miguel de la Hoya
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Vanesa Garcia-Barberan
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Kristiina Aittomäki
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Heli Nevanlinna
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Margreet G. E. M. Ausems
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - J. L. de Lange
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Encarna B. Gómez Garcia
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | | | - Frans B. L. Hogervorst
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Carolien M. Kets
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Hanne E. J. Meijers-Heijboer
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jan C. Oosterwijk
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Matti A. Rookus
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Christi J. van Asperen
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Ans M. W. van den Ouweland
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Helena C. van Doorn
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Theo A. M. van Os
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Ava Kwong
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Edith Olah
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Orland Diez
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Joan Brunet
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Conxi Lazaro
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Alex Teulé
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jacek Gronwald
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Anna Jakubowska
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Katarzyna Kaczmarek
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jan Lubinski
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Grzegorz Sukiennicki
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Rosa B. Barkardottir
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jocelyne Chiquette
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Simona Agata
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Marco Montagna
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Manuel R. Teixeira
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | | | - Sue Kyung Park
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Curtis Olswold
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Marc Tischkowitz
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Lenka Foretova
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Pragna Gaddam
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Joseph Vijai
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Georg Pfeiler
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Christine Rappaport-Fuerhauser
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Christian F. Singer
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Muy-Kheng M. Tea
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Mark H. Greene
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jennifer T. Loud
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Gad Rennert
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Evgeny N. Imyanitov
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Peter J. Hulick
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - John L. Hays
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Marion Piedmonte
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Gustavo C. Rodriguez
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Julie Martyn
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Gord Glendon
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Anna Marie Mulligan
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Irene L. Andrulis
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Amanda Ewart Toland
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Uffe Birk Jensen
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Torben A. Kruse
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Inge Sokilde Pedersen
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Mads Thomassen
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Maria A. Caligo
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Soo-Hwang Teo
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Raanan Berger
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Eitan Friedman
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Yael Laitman
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Brita Arver
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Ake Borg
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Hans Ehrencrona
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Johanna Rantala
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Olufunmilayo I. Olopade
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Patricia A. Ganz
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Robert L. Nussbaum
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Angela R. Bradbury
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Susan M. Domchek
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Katherine L. Nathanson
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Banu K. Arun
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Paul James
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Beth Y. Karlan
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jenny Lester
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Jacques Simard
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Paul D. P. Pharoah
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Kenneth Offit
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Fergus J. Couch
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Georgia Chenevix-Trench
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Douglas F. Easton
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| | - Antonis C. Antoniou
- Affiliations of authors: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK (KBK); Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (KBK, LM, DB, AL, JD, ML, NM, DFE, ACA); Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada (PS, JSi); Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (SHe); Clinical Genetics, Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (MR); Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS, GCT); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (SJR); Department of Epidemiology, Columbia University, New York, NY (MBT); Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA (SLN, YCD); Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany (UH); Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia (MS); Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA (EMJ); Departments of Pediatrics and Medicine, Columbia University, New York, NY (WKC); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA (MBD); Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT (SSB); Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT (DEG); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (CMD); Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa (EJvR); Department of Oncology (BE), Department of Clincial Genetics (AMG), and Center for Genomic Medicine (TVOH), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SS, EHal, CO); Human Genetics Group (JBe, AO) and Human Genotyping Unit, Human Cancer Genetics Program (JBe), Spanish National Cancer Centre , Madrid, Spain; Biomedical Network on Rare Diseases, CIBERER, Madrid, Spain (JBe, AO); City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA (NC, WL); Clinical Cancer Genetics, City of Hope, Duarte, California (JNW); IFOM, Institute of Molecular Oncology, Italian Foundation for Cancer Research, Milan, Italy (PP, VP); Cogentech Cancer Genetic Test Laboratory, Milan, Italy (VP); Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (RDo); University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (RDo); Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy (MB, BB); Unit of Medical Genetics (JAz, SMan, BPe) and Unit of Molecular Bases of Genetic Risk and Genetic Testing (PR), Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy;Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy (AS); Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy (LP); Department of Molecular Medicine, University La Sapienza, Rome, Italy (GGi); Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece (FF, IK); Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK (JAd); Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK (CB); Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK (JCo); Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK (RDa); University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK (DE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London UK (RE); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (SE, EMBRACE, DF); Medical Genetics Unit, St George's, University of London, London, UK (SHo); Clinical Genetics, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK (LI); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK (FLa); West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK (KrO); Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS (AKG); Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Germany (NA); Institute of Human Genetics, University of Münster, Münster, Germany (BD); Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany (CEn); Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Germany (AG); Center of Familial Breast and Ovarian Cancer, Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany (EHah, JH, RKS, BW); Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Germany (KKas); Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Germany (AM); Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany (DN); Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Germany (RVM); Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany (SWG); Bâtiment Cheney D, Centre Léon Bérard, Lyon, France (LB); Lyon Neuroscience Research Center- CRNL, Inserm U1028, CNRS UMR5292, University of Lyon, Lyon, France (SMaz); Service de Génétique Biologique, CHU de Besançon, Besançon, France (ACR); Service de Génétique, Institut Curie, Paris, France (CEl, LG); Institut Curie, Department of Tumour Biology, Paris, France (GEMO, DSL); Institut Curie, INSERM U830, Paris, France (GEMO, DSL); Université Paris Descartes, Sorbonne Paris Cité, France (GEMO, DSL); Oncogénétique, Institut Bergonié, Bordeaux, France (EBS); Genetic Epidemiology of Cancer team, Inserm U900, Paris, France (FLe); Institut Curie, Paris, France (FLe); Mines ParisTech, Fontainebleau, France (FLe); Laboratoire de Génétique Médicale, Nancy Université, Centre Hospitalier Régional et Universitaire, Vandoeuvre-les-Nancy, France (JSo); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI); Center for Medical Genetics, Ghent University, Gent, Belgium (KBMC, BPo); Molecular Oncology Laboratory, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain (MdlH, VGB); Department of Clinical Genetics, Helsinki University Hospital, HUS, Finland (KA); Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, HUS, Finland (HN); Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (MGEMA); Department of Epidemiology (JLdL) and Coordinating Center, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute, Amsterdam, the Netherlands (JLdL); Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, the Netherlands (EBGG); Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands (FBLH); Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (CMK); Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands (HEJMH); Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands (JCO); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR); Department of Clinical Genetics Leiden University Medical Center Leiden, Leiden, the Netherlands (CJvA); Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands (AMWvdO); Department of Gynaecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (HCvD); Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands (TAMvO); Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (AK); Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (AK); Department of Surgery, The University of Hong Kong, Hong Kong (AK); Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary (EO); Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain (OD); Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain (JBr); Molecular Diagnostic Unit (CL) and Genetic Counseling Unit (AT), Hereditary Cancer Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland (JG, AJ, KKac, JLu, GS); Laboratory of Cell Biology, Department of Pathology, Reykjavik, Iceland (RBB); Biomedical Centre, Faculty of Medicine, University of Iceland, Reykjavik, Iceland (RBB); Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, Canada (JCh); Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy (SA, MM); Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal (MRT); Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal (MRT); Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia (KConFab); Department of Preventive Medicine, Department of Biomedical Science, and Cancer Research Institute, Seoul National University, Seoul, Korea (SKP); Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada (MTi); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY (PG); Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (JV); Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center (GP), and Department of OB/GYN (CRF, CFS, MKMT), Medical University of Vienna, Vienna, Austria; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (MHG, JTL); Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel (GR); N. N. Petrov Institute of Oncology, St. Petersburg, Russia (ENI); Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, IL (PJH); The Ohio State University Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Columbus, OH (JLH); NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY (MP); Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL (GCR); ANZGOG, NHMRC Clinical Trials Centre, Camperdown, Australia (JM); Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (GGl); Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada (AMM); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (AMM); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (ILA); Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (ILA); Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH (AET); Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark (UBJ); Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark (TAK, MTh); Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark (ISP); Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy (MAC); Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia (SHT); University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia (SHT); The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel (RB); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (EF); Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (EF); The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel (YL); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (BA); Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden (AB); Department of Clinical Genetics, Lund University Hospital, Lund, Sweden (HE); Department of Clinical Genetics, Karolinska University Hospital L5:03, Stockholm, Sweden (JR); University of Chicago Medical Center, Chicago, IL (OIO); UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA (PAG); Medical Sciences, University of California, San Francisco, San Francisco, CA (RLN); Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (ARB, SMD, KLN); Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Andersson Cancer Center, Houston, TX (BKA); Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (PJ); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BYK, JLe); Department of Oncology, University of Cambridge, Cambridge, UK (PDPP); Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10044 (KO); Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN (FJC)
| |
Collapse
|
41
|
Mavaddat N, Pharoah PDP, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I, Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval C, van Limbergen E, Kristensen V, Grenaker Alnæs G, Nord S, Borresen-Dale AL, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV, Antonenkova NN, Dörk T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L, Devilee P, Tollenaar RAEM, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MWR, Khusnutdinova E, Bermisheva M, Prokofyeva D, Takhirova Z, Meindl A, Schmutzler RK, Sutter C, Yang R, Schürmann P, Bremer M, Christiansen H, Park-Simon TW, Hillemanns P, Guénel P, Truong T, Menegaux F, Sanchez M, Radice P, Peterlongo P, Manoukian S, Pensotti V, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Brauch H, Brüning T, Ko YD, Sigurdson AJ, Doody MM, Hamann U, Torres D, Ulmer HU, Försti A, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Andrulis IL, Knight JA, Glendon G, Marie Mulligan A, Chenevix-Trench G, Balleine R, Giles GG, Milne RL, McLean C, Lindblom A, Margolin S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Eilber U, Wang-Gohrke S, Hooning MJ, Hollestelle A, van den Ouweland AMW, Koppert LB, Carpenter J, Clarke C, Scott R, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Brenner H, Arndt V, Stegmaier C, Karina Dieffenbach A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Offit K, Vijai J, Robson M, Rau-Murthy R, Dwek M, Swann R, Annie Perkins K, Goldberg MS, Labrèche F, Dumont M, Eccles DM, Tapper WJ, Rafiq S, John EM, Whittemore AS, Slager S, Yannoukakos D, Toland AE, Yao S, Zheng W, Halverson SL, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Simard J, Hall P, Easton DF, Garcia-Closas M. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 2015; 107:djv036. [PMID: 25855707 PMCID: PMC4754625 DOI: 10.1093/jnci/djv036] [Citation(s) in RCA: 384] [Impact Index Per Article: 42.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2014] [Revised: 12/01/2014] [Accepted: 01/26/2015] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Data for multiple common susceptibility alleles for breast cancer may be combined to identify women at different levels of breast cancer risk. Such stratification could guide preventive and screening strategies. However, empirical evidence for genetic risk stratification is lacking. METHODS We investigated the value of using 77 breast cancer-associated single nucleotide polymorphisms (SNPs) for risk stratification, in a study of 33 673 breast cancer cases and 33 381 control women of European origin. We tested all possible pair-wise multiplicative interactions and constructed a 77-SNP polygenic risk score (PRS) for breast cancer overall and by estrogen receptor (ER) status. Absolute risks of breast cancer by PRS were derived from relative risk estimates and UK incidence and mortality rates. RESULTS There was no strong evidence for departure from a multiplicative model for any SNP pair. Women in the highest 1% of the PRS had a three-fold increased risk of developing breast cancer compared with women in the middle quintile (odds ratio [OR] = 3.36, 95% confidence interval [CI] = 2.95 to 3.83). The ORs for ER-positive and ER-negative disease were 3.73 (95% CI = 3.24 to 4.30) and 2.80 (95% CI = 2.26 to 3.46), respectively. Lifetime risk of breast cancer for women in the lowest and highest quintiles of the PRS were 5.2% and 16.6% for a woman without family history, and 8.6% and 24.4% for a woman with a first-degree family history of breast cancer. CONCLUSIONS The PRS stratifies breast cancer risk in women both with and without a family history of breast cancer. The observed level of risk discrimination could inform targeted screening and prevention strategies. Further discrimination may be achievable through combining the PRS with lifestyle/environmental factors, although these were not considered in this report.
Collapse
Affiliation(s)
- Nasim Mavaddat
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Paul D P Pharoah
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Kyriaki Michailidou
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jonathan Tyrer
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Mark N Brook
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Manjeet K Bolla
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Qin Wang
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Joe Dennis
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Alison M Dunning
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Mitul Shah
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Robert Luben
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Judith Brown
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Stig E Bojesen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Børge G Nordestgaard
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Sune F Nielsen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Henrik Flyger
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Kamila Czene
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Hatef Darabi
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Mikael Eriksson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Julian Peto
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Isabel Dos-Santos-Silva
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Frank Dudbridge
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Nichola Johnson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Marjanka K Schmidt
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Annegien Broeks
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Senno Verhoef
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Emiel J Rutgers
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Anthony Swerdlow
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Alan Ashworth
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Nick Orr
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Minouk J Schoemaker
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jonine Figueroa
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Stephen J Chanock
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Louise Brinton
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jolanta Lissowska
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Fergus J Couch
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Janet E Olson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Celine Vachon
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Vernon S Pankratz
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Diether Lambrechts
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Hans Wildiers
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Chantal Van Ongeval
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Erik van Limbergen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Vessela Kristensen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Grethe Grenaker Alnæs
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Silje Nord
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Anne-Lise Borresen-Dale
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Heli Nevanlinna
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Taru A Muranen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Kristiina Aittomäki
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Carl Blomqvist
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jenny Chang-Claude
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Anja Rudolph
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Petra Seibold
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Dieter Flesch-Janys
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Peter A Fasching
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Lothar Haeberle
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Arif B Ekici
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Matthias W Beckmann
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Barbara Burwinkel
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Frederik Marme
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Andreas Schneeweiss
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Christof Sohn
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Amy Trentham-Dietz
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Polly Newcomb
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Linda Titus
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Kathleen M Egan
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - David J Hunter
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Sara Lindstrom
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Rulla M Tamimi
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Peter Kraft
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Nazneen Rahman
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Clare Turnbull
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Anthony Renwick
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Sheila Seal
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jingmei Li
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jianjun Liu
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Keith Humphreys
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Javier Benitez
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - M Pilar Zamora
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jose Ignacio Arias Perez
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Primitiva Menéndez
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Anna Jakubowska
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jan Lubinski
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Katarzyna Jaworska-Bieniek
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Katarzyna Durda
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Natalia V Bogdanova
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Natalia N Antonenkova
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Thilo Dörk
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Hoda Anton-Culver
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Susan L Neuhausen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Argyrios Ziogas
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Leslie Bernstein
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Peter Devilee
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Robert A E M Tollenaar
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Caroline Seynaeve
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Christi J van Asperen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Angela Cox
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Simon S Cross
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Malcolm W R Reed
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Elza Khusnutdinova
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Marina Bermisheva
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Darya Prokofyeva
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Zalina Takhirova
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Alfons Meindl
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Rita K Schmutzler
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Christian Sutter
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Rongxi Yang
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Peter Schürmann
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Michael Bremer
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Hans Christiansen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Tjoung-Won Park-Simon
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Peter Hillemanns
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Pascal Guénel
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Thérèse Truong
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Florence Menegaux
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Marie Sanchez
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Paolo Radice
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Paolo Peterlongo
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Siranoush Manoukian
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Valeria Pensotti
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - John L Hopper
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Helen Tsimiklis
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Carmel Apicella
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Melissa C Southey
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Hiltrud Brauch
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Thomas Brüning
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Yon-Dschun Ko
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Alice J Sigurdson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Michele M Doody
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Ute Hamann
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Diana Torres
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Hans-Ulrich Ulmer
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Asta Försti
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Elinor J Sawyer
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Ian Tomlinson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Michael J Kerin
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Nicola Miller
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Irene L Andrulis
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Julia A Knight
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Gord Glendon
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Anna Marie Mulligan
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Georgia Chenevix-Trench
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Rosemary Balleine
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Graham G Giles
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Roger L Milne
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Catriona McLean
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Annika Lindblom
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Sara Margolin
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Christopher A Haiman
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Brian E Henderson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Fredrick Schumacher
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Loic Le Marchand
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Ursula Eilber
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Shan Wang-Gohrke
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Maartje J Hooning
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Antoinette Hollestelle
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Ans M W van den Ouweland
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Linetta B Koppert
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jane Carpenter
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Christine Clarke
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Rodney Scott
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Arto Mannermaa
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Vesa Kataja
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Veli-Matti Kosma
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jaana M Hartikainen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Hermann Brenner
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Volker Arndt
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Christa Stegmaier
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Aida Karina Dieffenbach
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Robert Winqvist
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Katri Pylkäs
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Arja Jukkola-Vuorinen
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Mervi Grip
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Kenneth Offit
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Joseph Vijai
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Mark Robson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Rohini Rau-Murthy
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Miriam Dwek
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Ruth Swann
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Katherine Annie Perkins
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Mark S Goldberg
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - France Labrèche
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Martine Dumont
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Diana M Eccles
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - William J Tapper
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Sajjad Rafiq
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Esther M John
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Alice S Whittemore
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Susan Slager
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Drakoulis Yannoukakos
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Amanda E Toland
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Song Yao
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Wei Zheng
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Sandra L Halverson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Anna González-Neira
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Guillermo Pita
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - M Rosario Alonso
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Nuria Álvarez
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Daniel Herrero
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Daniel C Tessier
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Daniel Vincent
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Francois Bacot
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Craig Luccarini
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Caroline Baynes
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Shahana Ahmed
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Mel Maranian
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Catherine S Healey
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Jacques Simard
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Per Hall
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Douglas F Easton
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| | - Montserrat Garcia-Closas
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (NM, PDPP, KM, MKB, QW, JD, RL, JBr, DFE); Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK (PDPP, JT, AMD, MS, CL, CB, SA, MM, CSH, DFE); Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK (MNB, ASw, MJS); Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark (SEB, BGN, SFN); Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN, SFN); Faculty of Health and Medical Sciences, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (SEB, BGN); Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Herlev, Denmark (HF); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, HD, ME, KH, PHa); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (JP, IdSS, FD); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (NJ, AA, NO, MGC); Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, AB, SV, EJR); Division of Breast Cancer Research, Institute of Cancer Research, London, UK (ASw); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (JF, SJC, LB, ASi, MD); Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (JLis); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JEO, CV, VSP, SS); Vesalius Research Center, VIB, Leuven, Belgium (DL); Laboratory for Translational Genetics, Department of Oncology, University of
| |
Collapse
|